Q3 2019 Johnson & Johnson Earnings Call Transcript
Good morning, and welcome to Johnson & Johnson's Third Quarter 2019 Earnings Conference Call. (Operator Instructions)
This call is being recorded. If anyone has any objections, you may disconnect at this time. (Operator Instructions) I would now like to turn the conference call over to Johnson & Johnson. You may begin.
Good morning. This is Chris DelOrefice, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company's review of business results for the third quarter of 2019. Joining me on today's call is Joe Wolk, Executive Vice President, Chief Financial Officer. Additionally during our Q&A session, Joe and I are pleased to be joined by Ashley McEvoy, Executive Vice President, Worldwide Chairman Medical Devices; Thibaut Mongon, Executive Vice President, Worldwide Chairman Consumer; and Jennifer Taubert, Executive Vice President, Worldwide Chairman Pharmaceuticals.
A few logistics before we get into the details. This review is being made available via
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |